Role of glycopeptides in the treatment of septic complications after cardiac surgery

Journal of Chemotherapy

Volumn 13, Issue SPEC. ISS. 1, 2001, Pages 112-118

  Bourgoin, A ^a   Leone M ^a   Martin, Claude ^a  

^a HÔPITAL NORD   (France)

Author keywords

Cardiac surgery sepsis; Glycopeptide; Prosthetic valve endocarditis; Sepsis; Teicoplanin; Vancomycin

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; DALFOPRISTIN PLUS QUINUPRISTIN; FOSFOMYCIN; FUSIDIC ACID; GLYCOPEPTIDE; LINEZOLID; METICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL ENDOCARDITIS; BACTERIUM ISOLATE; CONFERENCE PAPER; CONTINUOUS INFUSION; CORYNEBACTERIUM DIPHTHERIAE; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; EMBOLISM; ENTEROCOCCUS; GRAFT INFECTION; GRAM NEGATIVE BACTERIUM; HEART FAILURE; HEART SURGERY; HEART VALVE PROSTHESIS; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NEPHROTOXICITY; NONHUMAN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT FAILURE;

EID: 0035722960     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2001.13.supplement-2.112     Document Type: Conference Paper

References (40)

1. Prosthetic valve infective endocarditis
2. Risk factors for the development of prosthetic valve endocarditis
3. Infections of prosthetic heart valves and vascular grefts
4. Prosthetic valve endocarditis
5. Prosthetic valve endocarditis
6. Prosthetic valve endocarditis: Comparison of heterograft tissue valves and mechanical valves
7. Prosthetic valve endocarditis
8. Prosthetic valve endocarditis
9. Combination antibiotic therapy of bacterial endocarditis
10. Staphylococcus epidermidis prosthetic valve endocarditis: Microbiological and clinical observations as guides to therapy
11. Comparison of conventional dosing versus continuous infusion vancomycin therapy for patients with suspected or documented Gram positive infections
12. Pharmacokinetics of vancomycin
13. Etude pharmacocinétique de la vancomycine en perfusion continue dans le sérum et le LCR chez des patients sous ventilation mécanique
14. Pharmacokinetics of single- and multiple dose of teicoplanin in healthy volunteers
15. Pharmacokinetics and bioavailability of a new formulation of teicoplanin following intravenous and intramuscular administration to humans
16. Pharmacokinetics and tolerability of teicoplanin in healthy volunteers after single increasing doses
17. Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy
18. Binding of teicoplanin to human serum albumin
19. Pharmacokinetics of teicoplanin in subjects with varying degrees of renal function
20. Emergence of vancomycin resistance in coagulase-negative staphylococci
21. Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection
22. Glycopeptide tolerance in Staphylococcus aureus
23. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
24. The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan
25. Staphylococcus aureus with reduced susceptibility to vancomycin-United States
26. Recommendations for preventing the spread of vancomycin resistance: Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC)
27. Vancomycin Intermediate-resistant Staphylococcus aureus
28. Staphylococcus aureus infections
29. Emergence of vancomycin resistance in Staphylococcus aureus
30. New resistance in Staphylococcus aureus infection
31. Actived cell-wall synthesis is associated with vancomycin resistance in methcillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50
32. Increased production of penicillin binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus
33. Comparison of continuous with discontinuous infusion of vancomycin in severe MRSA infections
34. Continuous infusion of vancomycin for severe methicillin-resistant staphylococcal infections
35. Comparative penetration of 6 antibiotics into the cerebrospinal fluid of rabbits with experimental staphylococcal meningitis
36. Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit
37. Therapy of experimental Staphylococcus epidermidis endocarditis
38. Methicillin-resistant Staphylococcus epidermidis prosthetic valve endocarditis: A therapeutic trial
39. Surgical treatment of prosthetic valve endocarditis
40. Prosthetic valve endocarditis: Analysis of factors affecting outcome of therapy